Richard I Eisenstadt Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Richard I Eisenstadt.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Richard I Eisenstadt. Richard I Eisenstadt is VP, Finance & C.F.O. in Ocera Therapeutics, Inc. ($TZYM) and Chief Financial Officer in AYTU BIOPHARMA, INC ($AYTU) and Chief Financial Officer in Neos Therapeutics, Inc. ($NEOS).
Latest Insider Trading Transactions of Richard I Eisenstadt
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AYTU, NEOS, TZYM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 05 2021 | AYTU | AYTU BIOPHARMA, IN ... | Eisenstadt Richard I | Chief Financial Off ... | Grant | A | 0.00 | 55,000 | 0 | 68,734 | 13.7 K to 68.7 K (+400.47 %) |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | D | 1.49 | 115,000 | 171,350 | 0 | |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | D | 2.31 | 230,276 | 531,938 | 0 | |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | D | 8.30 | 56,250 | 466,875 | 0 | |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | D | 7.00 | 45,000 | 315,000 | 0 | |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | D | 10.74 | 50,000 | 537,000 | 0 | |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | D | 25.50 | 60,230 | 1,535,865 | 0 | |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | D | 9.32 | 12,500 | 116,500 | 0 | |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | D | 2.91 | 86,167 | 250,746 | 0 | |
| Mar 19 2021 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Sell | D | 0.00 | 126,245 | 0 | 0 | 126.2 K to 0 (-100.00 %) |
| Mar 16 2021 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Payment of Exercise | F | 0.84 | 14,825 | 12,512 | 126,245 | 141.1 K to 126.2 K (-10.51 %) |
| Mar 16 2021 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Payment of Exercise | F | 0.88 | 1,390 | 1,227 | 141,070 | 142.5 K to 141.1 K (-0.98 %) |
| Mar 04 2020 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | A | 1.49 | 115,000 | 171,350 | 115,000 | |
| Mar 04 2020 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Grant | A | 0.00 | 100,000 | 0 | 0 | -100,000 to 0 (-100.00 %) |
| Mar 04 2019 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | A | 2.31 | 230,276 | 531,938 | 230,276 | |
| Dec 13 2018 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Buy | P | 2.16 | 5,000 | 10,820 | 42,460 | 37.5 K to 42.5 K (+13.35 %) |
| Mar 05 2018 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | A | 8.30 | 56,250 | 466,875 | 56,250 | |
| Mar 05 2018 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Grant | A | 0.00 | 18,750 | 0 | 37,460 | 18.7 K to 37.5 K (+100.21 %) |
| May 02 2017 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | A | 7.00 | 45,000 | 315,000 | 45,000 | |
| May 02 2017 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Grant | A | 0.00 | 15,000 | 0 | 18,710 | 3.7 K to 18.7 K (+404.31 %) |
| Aug 25 2016 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Buy | P | 6.82 | 3,710 | 25,284 | 3,710 | 0 to 3.7 K |
| Apr 01 2016 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | A | 10.74 | 50,000 | 537,000 | 50,000 | |
| Sep 03 2015 | NEOS | Neos Therapeutics, ... | Eisenstadt Richard I | Chief Financial Off ... | Option Exercise | A | 25.50 | 60,230 | 1,535,865 | 60,230 | |
| Apr 21 2011 | TZYM | Ocera Therapeutics ... | Eisenstadt Richard I | VP, Finance & C.F.O ... | Option Exercise | A | 4.00 | 148,736 | 594,944 | 148,736 |
Page: 1